Apoptotic endonuclease EndoG induces alternative splicing of telomerase catalytic subunit hTERT and death of tumor cells

   
Zhdanov D.D.1 , Vasina D.A.2, Orlova V.S.2, Gotovtseva V.Y.3, Bibikova M.V.3, Pokrovsky V.S.4, Pokrovskaya M.V.4, Aleksandrova S.S.4, Sokolov N.N.4

1. Institute of Biomedical Chemistry, Moscow, Russia; Ecological Faculty, Peoples Friendship University of Russia, Moscow, Russia
2. Ecological Faculty, Peoples Friendship University of Russia, Moscow, Russia
3. ”Viorin” LLC, Moscow, Russia
4. Institute of Biomedical Chemistry, Moscow, Russia
Section: Experimental Study
DOI: 10.18097/PBMC20166203239      UDK: 577.218.214.5.24      PubMed Id: 27420614
Year: 2016  Volume: 62  Issue: 3  Pages: 239-250
Telomerase activity is known to be regulated by alternative splicing of its catalytic subunit hTERT (human Telomerase Reverse Transcriptase) mRNA. Induction of non-active spliced hTERT leads to inhibition of telomerase activity. However, very little is known about the mechanism of hTERT mRNA alternative splicing. The aim of this study was to determine the role of apoptotic endonuclease EndoG in alternative splicing of hTERT and telomerase activity. Strong correlation was found between expression of EndoG and hTERT splice-variants in 12 colon cancer cell lines. Overexpression of EndoG in СаСо-2 cells downregulated the expression of active full-length hTERT variant and upregulated non-active spliced variant. Reduction of full-length hTERT caused downregulation of telomerase activity, dramatically shortening of telomeres length during cell divisions, converting cells to the replicative senescence state, activation of apoptosis and finally cell death. These data indicated the participation of EndoG in alternative splicing of mRNA of telomerase catalytic subunit, regulation of telomerase activity and cell fate.
Download PDF:
Reference:

Zhdanov D.D., Vasina D.A., Orlova V.S., Gotovtseva V.Y., Bibikova M.V., Pokrovsky V.S., Pokrovskaya M.V., Aleksandrova S.S., Sokolov N.N. (2016) Biomeditsinskaya khimiya, 62(3), 239-250.
This paper is also available as the English translation:10.1134/S1990750816040090
References  
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)
        

© Institute of Biomedical Chemistry, Moscow, Russia